These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3784054)

  • 1. [A measurement of IgA-containing immune complexes by anti-C3 ELISA].
    Tanaka M
    Nihon Hifuka Gakkai Zasshi; 1986 Jul; 96(8):839-42. PubMed ID: 3784054
    [No Abstract]   [Full Text] [Related]  

  • 2. [The measurement of circulating immune complexes using anti-C3 antibody micro ELISA].
    Hayashi S; Aochi H; Nagamine K; Oshida M; Kurata Y; Kawagoe H
    Rinsho Byori; 1986 Dec; 34(12):1408-12. PubMed ID: 3560472
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of circulating immune complex levels by ELISA using F(ab')2 anti-C3 antibody].
    Muratsugu M; Makino M
    Rinsho Byori; 1986 Oct; Spec No 69():53-9. PubMed ID: 3806992
    [No Abstract]   [Full Text] [Related]  

  • 4. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
    Muratsugu M; Makino M; Kohda H; Sekiya C
    Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
    Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
    Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
    Casiglia D; Giardina E; Scarantino G; Triolo G
    Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
    Iida K; Mitomo K; Fujita T; Tamura N
    J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined IGG, IGM and IGA peroxidase conjugate can facilitate determination of immune complexes by CIF-ELISA and anti-C3 ELISA.
    Slavov E
    Folia Med (Plovdiv); 1999; 41(1):149-52. PubMed ID: 10462947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in IgA nephropathy (Berger's disease).
    Stachura I
    Pathol Annu; 1983; 18 Pt 2():295-314. PubMed ID: 6232491
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
    Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
    J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
    Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
    Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.
    Hall RP; Lawley TJ; Heck JA; Katz SI
    Clin Exp Immunol; 1980 Jun; 40(3):431-7. PubMed ID: 7418261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double immunofluorescence studies on IgA-associated immune-complexes in glomerular deposits in patients with IgA nephropathy.
    Tomino Y; Nomoto Y; Endoh M; Sakai H; Arimori S
    Tokai J Exp Clin Med; 1980 Apr; 5(2):147-9. PubMed ID: 6998050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgA dominant immune complexes on peripheral blood lymphocytes in patients with IgA nephropathy.
    Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Mar; 11(1):13-7. PubMed ID: 3544343
    [No Abstract]   [Full Text] [Related]  

  • 17. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3.
    Hosoda K; Sakurabayashi I; Kawai T; Suzuki H; Maeda M; Tsuji A
    J Immunol Methods; 1985 Oct; 82(2):243-52. PubMed ID: 3900216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin and complement deposits in the skin and circulating immune complexes in scabies.
    Salo OP; Reunala T; Kalimo K; Rantanen T
    Acta Derm Venereol; 1982; 62(1):73-6. PubMed ID: 6175145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of immunocomplexes. IV. Detection of immune complexes using the C3 and C4 component of complement].
    Votruba T; Rákosník P
    Cesk Epidemiol Mikrobiol Imunol; 1988 Jul; 37(4):199-206. PubMed ID: 2981003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.